Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Cohance Lifesciences Ltd

NSE: COHANCE · BSE: 543064 · Pharmaceuticals & Biotechnology · 10 announcements

Share price
₹459.25
Market cap
₹17,571 Cr
Revenue (annual)
₹2,269 Cr
Net profit (annual)
₹179.2 Cr
P/E (TTM)
165.4×Sector 50.4×
Promoter holding
57.49%+0.00% QoQ
FII holding
6.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

18:31 IST NSE
Merger & Restructuring

Cohance Lifesciences Merger & Restructuring Worth ₹95 Cr

Cohance Lifesciences invested USD 10 million (₹95 Crore) into its subsidiary NJ Bio, Inc. to subscribe for new Compulsorily Convertible Preferred Stock.

Value
₹95.00 Cr